Home > Publications database > Human genomics of the humoral immune response against polyomaviruses. > print

001     177003
005     20240229133728.0
024 7 _ |a 10.1093/ve/veab058
|2 doi
024 7 _ |a pmid:34532061
|2 pmid
024 7 _ |a pmc:PMC8438875
|2 pmc
037 _ _ |a DKFZ-2021-02236
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Hodel, F.
|0 0000-0001-7331-7357
|b 0
245 _ _ |a Human genomics of the humoral immune response against polyomaviruses.
260 _ _ |a Oxford
|c 2021
|b Oxford Univ. Press
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1635318133_28977
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Human polyomaviruses are widespread in humans and can cause severe disease in immunocompromised individuals. To identify human genetic determinants of the humoral immune response against polyomaviruses, we performed genome-wide association studies and meta-analyses of qualitative and quantitative immunoglobulin G responses against BK polyomavirus (BKPyV), JC polyomavirus (JCPyV), Merkel cellpolyomavirus (MCPyV), WU polyomavirus (WUPyV), and human polyomavirus 6 (HPyV6) in 15,660 individuals of European ancestry from three independent studies. We observed significant associations for all tested viruses: JCPyV, HPyV6, and MCPyV associated with human leukocyte antigen class II variation, BKPyV and JCPyV with variants in FUT2, responsible for secretor status, MCPyV with variants in STING1, involved in interferon induction, and WUPyV with a functional variant in MUC1, previously associated with risk for gastric cancer. These results provide insights into the genetic control of a family of very prevalent human viruses, highlighting genes and pathways that play a modulating role in human humoral immunity.
536 _ _ |a 316 - Infektionen, Entzündung und Krebs (POF4-316)
|0 G:(DE-HGF)POF4-316
|c POF4-316
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: inrepo01.inet.dkfz-heidelberg.de
650 _ 7 |a GWAS
|2 Other
650 _ 7 |a genomics
|2 Other
650 _ 7 |a human
|2 Other
650 _ 7 |a infection
|2 Other
650 _ 7 |a meta-analysis
|2 Other
650 _ 7 |a polyomavirus
|2 Other
700 1 _ |a Chong, A. Y.
|b 1
700 1 _ |a Scepanovic, P.
|b 2
700 1 _ |a Xu, Z. M.
|b 3
700 1 _ |a Naret, O.
|b 4
700 1 _ |a Thorball, C. W.
|b 5
700 1 _ |a Rüeger, S.
|b 6
700 1 _ |a Marques-Vidal, P.
|b 7
700 1 _ |a Vollenweider, P.
|0 0000-0002-0765-896X
|b 8
700 1 _ |a Begemann, M.
|b 9
700 1 _ |a Ehrenreich, H.
|b 10
700 1 _ |a Brenner, N.
|0 P:(DE-He78)b1326dc42cbbc5f92b10fe5f254f0bc2
|b 11
|u dkfz
700 1 _ |a Bender, N.
|0 P:(DE-He78)540833b33724d8def638cce2f0b4e187
|b 12
|u dkfz
700 1 _ |a Waterboer, T.
|0 P:(DE-He78)6b4ebb9791b983b5620c0caaf3468e30
|b 13
|u dkfz
700 1 _ |a Mentzer, A. J.
|0 0000-0002-4502-2209
|b 14
700 1 _ |a Hill, A. V. S.
|b 15
700 1 _ |a Hammer, C.
|0 0000-0003-4548-7548
|b 16
700 1 _ |a Fellay, J.
|b 17
773 _ _ |a 10.1093/ve/veab058
|g Vol. 7, no. 2, p. veab058
|0 PERI:(DE-600)2818949-8
|n 2
|p veab058
|t Virus evolution
|v 7
|y 2021
|x 2057-1577
909 C O |p VDB
|o oai:inrepo02.dkfz.de:177003
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 11
|6 P:(DE-He78)b1326dc42cbbc5f92b10fe5f254f0bc2
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 12
|6 P:(DE-He78)540833b33724d8def638cce2f0b4e187
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 13
|6 P:(DE-He78)6b4ebb9791b983b5620c0caaf3468e30
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF4-310
|0 G:(DE-HGF)POF4-316
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Infektionen, Entzündung und Krebs
|x 0
914 1 _ |y 2021
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2020-09-06
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0320
|2 StatID
|b PubMed Central
|d 2020-09-06
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0501
|2 StatID
|b DOAJ Seal
|d 2020-09-06
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0500
|2 StatID
|b DOAJ
|d 2020-09-06
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b DOAJ : Blind peer review
|d 2020-09-06
915 _ _ |a Creative Commons Attribution-NonCommercial CC BY-NC (No Version)
|0 LIC:(DE-HGF)CCBYNCNV
|2 V:(DE-HGF)
|b DOAJ
|d 2020-09-06
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2020-09-06
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2020-09-06
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2020-09-06
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2020-09-06
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2020-09-06
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2020-09-06
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2020-09-06
920 1 _ |0 I:(DE-He78)F022-20160331
|k F022
|l Infektionen und Krebs-Epidemiologie
|x 0
920 1 _ |0 I:(DE-He78)F020-20160331
|k F020
|l Infektionen und Krebs-Epidemiologie
|x 1
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)F022-20160331
980 _ _ |a I:(DE-He78)F020-20160331
980 _ _ |a UNRESTRICTED

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21